Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic and epigenomic alterations in prostate cancer.
Aschelter AM, Giacinti S, Caporello P, Marchetti P. Aschelter AM, et al. Among authors: giacinti s. Front Endocrinol (Lausanne). 2012 Nov 6;3:128. doi: 10.3389/fendo.2012.00128. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 23133437 Free PMC article.
Duration of response to first androgen deprivation therapy, time to castration resistance prostate cancer, and outcome of metastatic castration resistance prostate cancer patients treated with abiraterone acetate.
Giacinti S, Carlini P, Roberto M, Bassanelli M, Strigari L, Pavese F, Aschelter AM, Felici A, Valeriani M, Cognetti F, Marchetti P. Giacinti S, et al. Anticancer Drugs. 2017 Jan;28(1):110-115. doi: 10.1097/CAD.0000000000000434. Anticancer Drugs. 2017. PMID: 27763885
Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients' Satisfaction.
Cindolo L, Natoli C, De Nunzio C, De Tursi M, Valeriani M, Giacinti S, Micali S, Rizzo M, Bianchi G, Martorana E, Scarcia M, Ludovico GM, Bove P, Laudisi A, Selvaggio O, Carrieri G, Bada M, Castellan P, Topazio L, Boccasile S, Ditonno P, Chiodini P, Schips L. Cindolo L, et al. Among authors: giacinti s. Clin Genitourin Cancer. 2017 Oct;15(5):520-525. doi: 10.1016/j.clgc.2017.04.003. Epub 2017 Apr 11. Clin Genitourin Cancer. 2017. PMID: 28478884 Clinical Trial.
Castration-resistance prostate cancer: what is in the pipeline?
DE Nunzio C, Presicce F, Giacinti S, Bassanelli M, Tubaro A. DE Nunzio C, et al. Among authors: giacinti s. Minerva Urol Nefrol. 2018 Feb;70(1):22-41. doi: 10.23736/S0393-2249.17.02976-9. Epub 2017 Jul 12. Minerva Urol Nefrol. 2018. PMID: 28707844 Free article. Review.
Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter "real life" study.
Cindolo L, Natoli C, De Nunzio C, De Tursi M, Valeriani M, Giacinti S, Micali S, Rizzo M, Bianchi G, Martorana E, Scarcia M, Ludovico GM, Bove P, Laudisi A, Selvaggio O, Carrieri G, Bada M, Castellan P, Boccasile S, Ditonno P, Chiodini P, Verze P, Mirone V, Schips L. Cindolo L, et al. Among authors: giacinti s. BMC Cancer. 2017 Nov 10;17(1):753. doi: 10.1186/s12885-017-3755-x. BMC Cancer. 2017. PMID: 29126389 Free PMC article. Clinical Trial.
Heterogeneity of PD-L1 Expression and Relationship with Biology of NSCLC.
Bassanelli M, Sioletic S, Martini M, Giacinti S, Viterbo A, Staddon A, Liberati F, Ceribelli A. Bassanelli M, et al. Among authors: giacinti s. Anticancer Res. 2018 Jul;38(7):3789-3796. doi: 10.21873/anticanres.12662. Anticancer Res. 2018. PMID: 29970498 Review.
Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohort.
Ferriero M, Mastroianni R, De Nunzio C, Cindolo L, Calabrò F, Tema G, Leonardo C, Flammia RS, Tuderti G, Anceschi U, Brassetti A, Giacinti S, Guaglianone S, Ghahhari J, Schips L, Tubaro A, Gallucci M, Simone G. Ferriero M, et al. Among authors: giacinti s. World J Urol. 2020 Jul;38(7):1757-1764. doi: 10.1007/s00345-019-02974-6. Epub 2019 Oct 12. World J Urol. 2020. PMID: 31605196
15 results